» Portfolio News

03.10.17

NOXXON publishes preclinical Proof-of-Concept Data for Lead Product NOX-A12 in Combination with Checkpoint Inhibitors

Read more...

29.09.17

NOXXON Supervisory Board elects experienced US & EU Biotech Veteran Don deBethizy Chairman

Read more...

28.09.17

NOXXON provides Update on ongoing Phase 1/2 clinical Trial with Lead Program NOX-A12

Read more...

18.07.17

NOXXON issues first Tranche of ODIRNANE Bonds

Read more...

11.07.17

NOXXON Pharma announces Prospectus Publication and Share Transfer to the Public Offering Compartment of the Euronext Growth Market 

Read more...

Portfolio

As of June 2018

 

 

Company   Investment

Lloyd Fonds AG, Hamburg

Listed investment and asset manager

read more »

 

28.4% 

Decimo GmbH, Berlin

Cloud-based factoring solutions for freelancers and SMEs, fully automated processing ensures fast and easy prefinancing of even smaller invoices

read more »

 

22.9%

MueTec Automatisierte Mikroskopie und Messtechnik GmbH, Munich

High precision, optical measurement and inspection solutions for semiconductor and microelectronics industries

read more »

 

92.0% 

LemnaTec GmbH, Aachen

Automated hard- and software solutions for image analysis and digital phenotyping

read more »

 

49.7%


NOXXON Pharma AG, Berlin

Development of pharmaceuticals on the basis of Spiegelmer technology
read more »

 

 

8.1%